LifeStance Health Finalizes Secondary Offering Terms, Repurchases 7 Million Shares
LFST sits 86% above its 52-week low of $3.74 on elevated volume (5.1× avg).
Summary
LifeStance Health Group finalized the terms for a secondary offering where institutional investors will sell 25 million shares, while the company will repurchase 7 million shares at $7.01 per share, reducing its total outstanding shares.
Key Events · Financing and Capital Events · LFST
-
Secondary Offering Finalized
Institutional investors (TPG and Summit Partners) are selling 25,000,000 shares of common stock at $7.01 per share, generating $175.25 million in proceeds for them. This finalizes the terms of the offering initiated on February 26, 2026.
-
Company Share Repurchase
LifeStance Health Group will repurchase 7,000,000 shares from the underwriter at the offering price of $7.01 per share, totaling $49.07 million. These shares will be retired, reducing the total outstanding share count.
-
Net Share Reduction
The company's repurchase of 7 million shares will result in a net decrease of outstanding shares, despite the larger institutional sale, demonstrating capital management.
-
No Proceeds to Company from Secondary Sale
The company will not receive any proceeds from the sale of shares by the selling stockholders.
Analysis · LFST · Industrial Applications And Services
This filing finalizes the pricing and terms of the secondary offering and share repurchase program previously initiated on February 26, 2026. While institutional investors are selling a substantial 25 million shares, the company's commitment to repurchase 7 million shares at $7.01 per share is a significant positive signal. This repurchase, valued at $49.07 million, will reduce the total outstanding shares, demonstrating management's confidence and utilizing a portion of the recently announced $100 million share repurchase program. The offering price is a slight discount to the last reported price but aligns closely with the current market, indicating a reasonable valuation for the transaction.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 29.5% of the 1672 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.22%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LFST was trading at $6.95 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $3.74 to $8.30. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.